Royalty Pharma
RPRX
RPRX
123 hedge funds and large institutions have $7.04B invested in Royalty Pharma in 2020 Q2 according to their latest regulatory filings, with 122 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
Holders
123
Holding in Top 10
7
Calls
$2.63M
Puts
$1.54M
Top Buyers
| 1 | +$2.23B | |
| 2 | +$743M | |
| 3 | +$713M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$395M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$389M |
Top Sellers
No sellers this quarter